{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":19,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":19,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c98e8d888c40","filters":{"venue":"Future Rare Diseases"}},"results":[{"id":"W3128891271","doi":"10.2217/frd-2020-0006","title":"Transfusion of Modified Blood Components for the Treatment of Autoimmune Hemolytic Anemia: A Network Meta-Analysis","year":2021,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Blood groups and transfusion","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Medicine; Incidence (geometry); Autoimmune hemolytic anemia; Adverse effect; Anemia; Randomized controlled trial; Internal medicine; Immunology; Hemoglobin; Hemolytic anemia; Meta-analysis","authors":[{"name":"Jiawen Deng","is_ca":true},{"name":"Fangwen Zhou","is_ca":true},{"name":"Chi Yi Wong","is_ca":true},{"name":"Elena Zheng","is_ca":true},{"name":"Emma Huang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04117066970733201,"gpt":0.2736758022095728,"spread":0.2325051325022408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005559508,0.0002076992,0.001231241,0.00006025363,0.0001145663,0.000007462337,0.00008233671,0.00009182613,0.0003029555],"category_scores_gemma":[0.000008255692,0.0001152642,0.002436178,0.0005730365,0.00005147785,0.00002554027,0.000009232617,0.00005587602,3.725548e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001387292,"about_ca_system_score_gemma":0.00008614662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001070496,"about_ca_topic_score_gemma":0.00006906173,"domain_scores_codex":[0.9987681,0.00006508957,0.0004016009,0.0002820657,0.0002919878,0.0001911547],"domain_scores_gemma":[0.998796,0.0002467891,0.0001164517,0.0005617311,0.0001829297,0.00009609921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.008267432,0.0324255,0.0340763,0.0032557,0.8482531,0.0005707754,0.003158802,0.008882517,0.03135699,0.001505018,0.0009757206,0.02727218],"study_design_scores_gemma":[0.005755915,0.0008451932,0.09107821,0.00003490456,0.8908886,0.00001821627,0.0003616278,0.001002991,0.007617305,0.0001032536,0.002136399,0.0001573827],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7834058,0.2088514,0.001909095,0.002812012,0.0002703495,0.001501231,0.001113443,0.00004570548,0.00009094409],"genre_scores_gemma":[0.9943702,0.003755646,0.0004423766,0.0001082687,0.0002625478,0.0001160793,0.0007582798,0.00001976984,0.0001668213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2109644,"threshold_uncertainty_score":0.4700339,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413087173","doi":"10.1080/23995270.2025.2532358","title":"How I treat Rett syndrome with trofinetide: changes in dosing frequency and administration with rice cereal","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"ACADIA Pharmaceuticals","keywords":"Rett syndrome; Dosing; Administration (probate law); Medicine; Pharmacology; Biology; Biochemistry","authors":[{"name":"Arthur Beisang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003708007814534904,"gpt":0.2030145050772743,"spread":0.1993064972627394,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001291256,0.000161892,0.0001167229,0.00005656696,0.00006251877,0.00005765108,0.00006747963,0.00006494449,0.000003208021],"category_scores_gemma":[0.000008900563,0.0001242496,0.00001692518,0.0001429691,0.00005120187,0.000005641278,0.00002652418,0.00004680072,1.672122e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001037828,"about_ca_system_score_gemma":0.0001098303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001356702,"about_ca_topic_score_gemma":0.0009686715,"domain_scores_codex":[0.9993358,0.00002563848,0.00006784088,0.0003284597,0.00008320164,0.0001590754],"domain_scores_gemma":[0.9997185,0.000005462699,0.00003497704,0.0001501315,0.00002878093,0.00006208625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00212193,0.0005533005,0.7519497,0.0008691717,0.000236192,0.000726371,0.0002343217,0.00001759094,0.2217209,0.000375935,0.002840208,0.01835435],"study_design_scores_gemma":[0.00110276,0.0008053153,0.9819856,0.00009226383,0.00005883902,0.00007005499,0.0005952517,0.000002547881,0.01302215,0.00004527594,0.001969668,0.0002502553],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937753,0.003410059,0.00004277616,0.00203073,0.00004355067,0.0002051798,0.00006425895,0.00001085668,0.0004172675],"genre_scores_gemma":[0.9981172,0.0005146421,0.0003118596,0.0002636951,0.000030919,0.00004313529,0.0003051261,0.00001380499,0.0003996268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2300359,"threshold_uncertainty_score":0.5066751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4317212031","doi":"10.2217/frd-2022-0015","title":"The Effects of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva: A Plain Language Summary","year":2023,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"Daiichi Sankyo Europe; UCB Pharma; Incyte; BioCryst; Mead Johnson Nutrition; International Fibrodysplasia Ossificans Progressiva Association; Ultragenyx Pharmaceutical; Ipsen; Regeneron Pharmaceuticals; Pfizer","keywords":"Fibrodysplasia ossificans progressiva; Clinical trial; Medicine; Heterotopic bone; Myositis ossificans; Physical therapy; Bone formation; Dentistry; Surgery; Heterotopic ossification; Internal medicine","authors":[{"name":"Robert J. Pignolo","is_ca":false},{"name":"Edward C. Hsiao","is_ca":false},{"name":"Mona Al Mukaddam","is_ca":false},{"name":"Geneviève Baujat","is_ca":false},{"name":"Staffan K. Berglund","is_ca":false},{"name":"Matthew Brown","is_ca":false},{"name":"Angela M. Cheung","is_ca":true},{"name":"Carmen De Cunto","is_ca":false},{"name":"Patricia Delai","is_ca":false},{"name":"Nobuhiko Haga","is_ca":false},{"name":"Pekka Kannus","is_ca":true},{"name":"Richard Keen","is_ca":false},{"name":"Kim‐Hanh Le Quan Sang","is_ca":false},{"name":"Edna E. Mancilla","is_ca":false},{"name":"Rose Marino","is_ca":false},{"name":"Andrew Strahs","is_ca":false},{"name":"Frederick S. Kaplan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.002490181814365724,"gpt":0.2267368739953984,"spread":0.2242466921810327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003085102,0.0001047354,0.0001578267,0.0000992089,0.00009816997,0.00001346276,0.00008081952,0.00006795013,0.00002583019],"category_scores_gemma":[0.0001187189,0.00005712542,0.00005962728,0.000446191,0.00008901479,0.0000372953,0.00001619069,0.000131783,0.00001620403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002309602,"about_ca_system_score_gemma":0.00009284024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005207675,"about_ca_topic_score_gemma":0.000008857719,"domain_scores_codex":[0.9992088,0.00005759683,0.0001642449,0.000159375,0.0002271579,0.0001828453],"domain_scores_gemma":[0.999335,0.0001474532,0.00006464013,0.0002922246,0.00005323901,0.0001074373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006202261,0.0006201103,0.9601692,0.0008029721,0.0001876346,0.0003517505,0.001193978,0.000003079893,0.0002819157,0.0003019169,0.010207,0.02526019],"study_design_scores_gemma":[0.001945332,0.000205765,0.9930654,0.0004781424,0.00007113966,0.000001500036,0.0006426238,0.00001253,0.0001808258,0.00001312685,0.00331103,0.00007264669],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962214,0.0009076697,0.000002151387,0.001179557,0.0001963054,0.001021206,0.0001095726,0.0001042291,0.0002578862],"genre_scores_gemma":[0.9980898,0.0000734028,0.00001926606,0.00007406747,0.0001333354,0.0001938327,0.0006226239,0.00001585344,0.0007778223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03289612,"threshold_uncertainty_score":0.2329507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4406721598","doi":"10.1080/23995270.2024.2444861","title":"The effects of elafibranor in people with primary biliary cholangitis: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Nutrition Society; Canadian Paediatric Society; Canadian Cardiovascular Society; University of Calgary","funders":"Ipsen; Astellas Pharma; Fonds Wetenschappelijk Onderzoek; Boston Scientific Corporation; Gilead Sciences; GlaxoSmithKline; U.S. Department of Justice; AstraZeneca; Vlaamse regering; Dr. Falk Pharma; Pfizer; Novo Nordisk","keywords":"Plain language; Medicine; Primary (astronomy); General surgery; Internal medicine; Geography; Linguistics; Physics; Astrophysics; Philosophy","authors":[{"name":"Kris V. Kowdley","is_ca":false},{"name":"Christopher L. Bowlus","is_ca":false},{"name":"Cynthia Levy","is_ca":false},{"name":"Ulus Salih Akarca","is_ca":false},{"name":"Mário Reis Álvares‐da‐Silva","is_ca":false},{"name":"Pietro Andreoné","is_ca":false},{"name":"Marco Arrese","is_ca":false},{"name":"Sven Francque","is_ca":false},{"name":"Michael A. Heneghan","is_ca":false},{"name":"Pietro Invernizzi","is_ca":false},{"name":"D. I. Jones","is_ca":false},{"name":"Eric Lawitz","is_ca":false},{"name":"Marlyn J. Mayo","is_ca":false},{"name":"Mark G. Swain","is_ca":true},{"name":"Vı́ctor Vargas","is_ca":false},{"name":"John M. Vierling","is_ca":false},{"name":"Alejandra Villamil","is_ca":false},{"name":"Carol Addy","is_ca":false},{"name":"Julie Dietrich","is_ca":false},{"name":"Sarah Mazain","is_ca":false},{"name":"Bachirou Taddé","is_ca":false},{"name":"Benjamin F. Miller","is_ca":false},{"name":"Jianfen Shu","is_ca":false},{"name":"Claudia O. Zein","is_ca":false},{"name":"Carol L. Roberts","is_ca":false},{"name":"Gail E. Wright","is_ca":true},{"name":"Jörn M. Schattenberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.001457834398396568,"gpt":0.2084211682640114,"spread":0.2069633338656148,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005254898,0.0001550648,0.0002984376,0.0001082249,0.0001003331,0.00002042827,0.000157373,0.00005612064,0.00002558476],"category_scores_gemma":[0.0001434267,0.00009165015,0.0001274935,0.0004396146,0.0000814278,0.0001031852,0.00007315062,0.0001665041,0.000002627312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006737656,"about_ca_system_score_gemma":0.000401062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001989114,"about_ca_topic_score_gemma":0.0001167904,"domain_scores_codex":[0.9991201,0.0001093372,0.0001699627,0.000186701,0.0001978072,0.0002161566],"domain_scores_gemma":[0.9989049,0.0004162318,0.00005202695,0.0004699771,0.00004817322,0.0001086731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002809193,0.0007827224,0.957637,0.004123078,0.0002855306,0.0003852945,0.0007925731,0.000001042519,0.0007051231,0.0002371728,0.0161553,0.01608603],"study_design_scores_gemma":[0.002198589,0.0002029786,0.9906218,0.001243962,0.0003209253,0.000006168616,0.002031889,0.000004863002,0.0003409382,0.00003224038,0.002894049,0.000101606],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9357398,0.06063112,0.000004374901,0.0006684994,0.0002280805,0.0007111239,0.0001605449,0.00005670524,0.001799735],"genre_scores_gemma":[0.9960408,0.001083133,0.0000353982,0.0009851954,0.0002044187,0.00009884866,0.0003513171,0.00001982718,0.001181025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06030102,"threshold_uncertainty_score":0.3737385,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4417216476","doi":"10.1080/23995270.2025.2597031","title":"Real-world use of trofinetide: a survey of practices from prescribers at Rett syndrome centers of excellence in the United States","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Excellence; Rett syndrome; MEDLINE; CLARITY","authors":[{"name":"Erin Prange","is_ca":false},{"name":"David N. Lieberman","is_ca":false},{"name":"Grace Correa","is_ca":false},{"name":"Christopher W. Beatty","is_ca":false},{"name":"Arthur Beisang","is_ca":false},{"name":"Emily de los Reyes","is_ca":false},{"name":"Davut Pehli̇van","is_ca":false},{"name":"Alan K. Percy","is_ca":false},{"name":"Robin Ryther","is_ca":false},{"name":"Steven A. Skinner","is_ca":false},{"name":"Bernhard Suter","is_ca":false},{"name":"Louise Cosand","is_ca":false},{"name":"Alyssa M. Peckham","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02088355461246003,"gpt":0.2703077714047165,"spread":0.2494242167922564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000826448,0.0001298749,0.0001903389,0.000104196,0.00002513207,0.000008549197,0.0002648272,0.00005033062,0.00001571546],"category_scores_gemma":[0.0002325704,0.0001023406,0.00006660511,0.0003896361,0.0001070542,0.000005577031,0.0001259736,0.00004925176,1.926667e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008383222,"about_ca_system_score_gemma":0.00008659577,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007188057,"about_ca_topic_score_gemma":0.005479296,"domain_scores_codex":[0.9989095,0.0002639071,0.000304316,0.0002416063,0.0001529,0.0001277519],"domain_scores_gemma":[0.9990321,0.0001734353,0.0003103639,0.0003481859,0.0001035931,0.0000322892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008614112,0.0003071026,0.9393605,0.000173797,0.0001277216,0.000008895831,0.0002163971,0.0002964722,0.04836598,0.000009971582,0.01014128,0.0001305045],"study_design_scores_gemma":[0.0003824533,0.00009404105,0.9818906,0.00008276385,0.00004609274,4.859097e-7,0.0004927597,0.00002339764,0.01325162,0.000014893,0.003632242,0.00008864917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962767,0.001384987,0.000004657385,0.0002182287,0.0001028313,0.0002207503,0.001736905,0.000002703788,0.00005222197],"genre_scores_gemma":[0.9936131,0.00337585,0.00008740522,0.0001668505,0.000004787585,0.0000116547,0.002580044,0.000009212888,0.0001511504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04253013,"threshold_uncertainty_score":0.9994231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394716792","doi":"10.2217/frd-2023-0028","title":"The effects of garetosmab in people with fibrodysplasia ossificans progressiva (FOP): A plain language summary of the LUMINA-1 study","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Medicine; Plain language; Anatomy; Linguistics; Heterotopic ossification","authors":[{"name":"Maja Di Rocco","is_ca":false},{"name":"Robert J. Pignolo","is_ca":false},{"name":"Richard Keen","is_ca":false},{"name":"Dushyanth Srinivasan","is_ca":false},{"name":"Scott Mellis","is_ca":false},{"name":"Michelle Davis","is_ca":false},{"name":"Philippe Orcel","is_ca":false},{"name":"Christian Roux","is_ca":false},{"name":"Małgorzata Szczepanek","is_ca":false},{"name":"Javier Bachiller‐Corral","is_ca":false},{"name":"Angela M. Cheung","is_ca":true},{"name":"Kathryn Dahir","is_ca":false},{"name":"Mona Al Mukaddam","is_ca":false},{"name":"Anita Boyapati","is_ca":false},{"name":"Kusha Mohammadi","is_ca":false},{"name":"Aris N. Economides","is_ca":false},{"name":"Robert J. Sanchez","is_ca":false},{"name":"Dinko González Trotter","is_ca":false},{"name":"Susan Rhee","is_ca":false},{"name":"Gary Herman","is_ca":false},{"name":"Richard DelGizzi","is_ca":false},{"name":"George D. Yancopoulos","is_ca":false},{"name":"Elisabeth M. W. Eekhoff","is_ca":false},{"name":"Frederick S. Kaplan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.002619215020641179,"gpt":0.2444963067147385,"spread":0.2418770916940973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005327259,0.0001186445,0.0001982083,0.00007151212,0.00009085332,0.00002230928,0.0001425101,0.00005733687,0.00003530111],"category_scores_gemma":[0.0001019413,0.00005365175,0.0001001817,0.0004756695,0.0001317362,0.00003724582,0.0000267291,0.0002035857,0.000002272967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003084768,"about_ca_system_score_gemma":0.0002459737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002315006,"about_ca_topic_score_gemma":0.0001543777,"domain_scores_codex":[0.9990914,0.0001256159,0.000193827,0.0001838579,0.0002655271,0.0001397901],"domain_scores_gemma":[0.9991444,0.0002519063,0.00006548742,0.0004264049,0.00004335571,0.00006841151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007393542,0.002781604,0.9193048,0.005051444,0.0008856458,0.0009960324,0.02992378,0.000005686452,0.002290082,0.001220729,0.01105593,0.02574491],"study_design_scores_gemma":[0.001180853,0.0004514385,0.9770522,0.001755727,0.0003770201,0.00002544284,0.01519705,0.00004479048,0.0009373525,0.00001128374,0.002876864,0.00008993845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889253,0.00683678,0.000002675672,0.001692944,0.0003178175,0.001676835,0.00009027654,0.00005036412,0.0004069411],"genre_scores_gemma":[0.9983383,0.00005347288,0.000006879381,0.00003108982,0.0001374305,0.0002487671,0.00004437903,0.0000156944,0.001123937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05774744,"threshold_uncertainty_score":0.2187855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7117318193","doi":"10.1080/23995270.2025.2607961","title":"The plight of rare diseases in Southern Africa: health and social services policy recommendations","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Aga Khan Foundation","funders":"","keywords":"Social Welfare; Health services; Social policy; Government (linguistics); Health policy; Public health","authors":[{"name":"Aneth David","is_ca":false},{"name":"Mohamed Zahir Alimohamed","is_ca":false},{"name":"Grantina Modern","is_ca":false},{"name":"Sharifa Mbarak","is_ca":true},{"name":"Husna Mad-hy","is_ca":true},{"name":"B. Ozcan","is_ca":false},{"name":"Nomsa Mtshali","is_ca":false},{"name":"Hlumela Tshijila","is_ca":false},{"name":"Kelly du Plessis","is_ca":false},{"name":"Eda Selebatso","is_ca":false},{"name":"Matshediso Letsholo","is_ca":false},{"name":"Nthabeleng Ramoeli","is_ca":false},{"name":"Trudy Nyakambangwe","is_ca":false},{"name":"Reon Van Der Merwe","is_ca":false},{"name":"Vivian Joseph","is_ca":false},{"name":"Farhan Yusuf","is_ca":false},{"name":"Maximilian Godwin Kilipamwambu","is_ca":false},{"name":"Kilaza Samson Mwaikono","is_ca":false},{"name":"Siana Nkya","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004839057227458282,"gpt":0.2559353968020466,"spread":0.2510963395745883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004233725,0.0001611928,0.0001880249,0.00008579411,0.0003566278,0.00004931287,0.0002278025,0.00007300054,0.000007574101],"category_scores_gemma":[0.00003076138,0.0001204659,0.0001195152,0.0001920413,0.00009422196,0.000005459538,0.0001602216,0.00005373772,0.000001201199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002329992,"about_ca_system_score_gemma":0.0005213782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009185784,"about_ca_topic_score_gemma":0.0003595795,"domain_scores_codex":[0.9990404,0.0001025127,0.0002455209,0.0002779425,0.00008666448,0.0002470171],"domain_scores_gemma":[0.9994125,0.00003180893,0.0001170259,0.0002471024,0.00006988138,0.0001216922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004004754,0.003601545,0.46367,0.005918866,0.00166773,0.00005473639,0.0175514,0.00006270021,0.004178933,0.03177336,0.2581994,0.2093166],"study_design_scores_gemma":[0.001923538,0.0002068083,0.1366447,0.000250529,0.0001519477,0.00000411491,0.05886054,0.00002453448,0.0002139781,0.003647303,0.7975308,0.0005412127],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8339411,0.1268512,0.00001900406,0.02914486,0.0005689483,0.0006734967,0.008182962,0.00003763919,0.0005808361],"genre_scores_gemma":[0.9939516,0.002291028,0.00002150581,0.001078914,0.0005566585,0.00005328091,0.001468917,0.00001661093,0.000561507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5393314,"threshold_uncertainty_score":0.4912456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390113708","doi":"10.2217/frd-2023-0022","title":"Garadacimab for the prevention of hereditary angioedema attacks: a plain language summary of the VANGUARD study","year":2023,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Alberta; Ottawa Allergy Research Corporation; University of Ottawa","funders":"","keywords":"Hereditary angioedema; Vanguard; Placebo; Medicine; C1-inhibitor; Angioedema; Surgery; Internal medicine; Dermatology; Alternative medicine; Pathology","authors":[{"name":"Timothy Craig","is_ca":false},{"name":"Avner Reshef","is_ca":false},{"name":"H. Henry Li","is_ca":false},{"name":"Joshua Jacobs","is_ca":false},{"name":"Jonathan A. Bernstein","is_ca":false},{"name":"Henriette Farkas","is_ca":false},{"name":"William H. Yang","is_ca":true},{"name":"Erik S.G. Stroes","is_ca":false},{"name":"Isao Ohsawa","is_ca":false},{"name":"Raffi Tachdjian","is_ca":false},{"name":"Michael Manning","is_ca":false},{"name":"William R. Lumry","is_ca":false},{"name":"Inmaculada Martinez Saguer","is_ca":false},{"name":"Emel Aygören‐Pürsün","is_ca":false},{"name":"Bruce Ritchie","is_ca":true},{"name":"Gordon Sussman","is_ca":true},{"name":"John Anderson","is_ca":false},{"name":"Kimito Kawahata","is_ca":false},{"name":"Yusuke Suzuki","is_ca":false},{"name":"Petra Staubach","is_ca":false},{"name":"Regina Treudler","is_ca":false},{"name":"Henrike Feuersenger","is_ca":false},{"name":"Lolis Wieman","is_ca":false},{"name":"Iris Jacobs","is_ca":false},{"name":"Markus Magerl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01585118232168862,"gpt":0.2990552740792299,"spread":0.2832040917575413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001865443,0.0001666824,0.0003311649,0.00007900564,0.0001458812,0.000008896199,0.0002106213,0.0000625908,0.00008329465],"category_scores_gemma":[0.0002001696,0.00009556542,0.0004767766,0.0004540836,0.00008180516,0.0000716224,0.00006154019,0.00006806744,0.000003384793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002207332,"about_ca_system_score_gemma":0.0001508589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006056518,"about_ca_topic_score_gemma":0.0001025501,"domain_scores_codex":[0.9987499,0.00008962445,0.0003395381,0.0002227979,0.0003935266,0.000204584],"domain_scores_gemma":[0.9987499,0.0003556863,0.0001838131,0.0005318316,0.0001112944,0.00006746377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002506182,0.002750863,0.5779334,0.002038319,0.001751227,0.0001353456,0.0180637,0.00014038,0.001161487,0.0003873998,0.3384897,0.0546421],"study_design_scores_gemma":[0.002275289,0.0004652275,0.955214,0.0003488704,0.001041421,0.00000940174,0.03433704,0.0002494337,0.0008284643,0.0001382026,0.004954498,0.0001381651],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757013,0.01897339,0.00003226911,0.001462026,0.0007947736,0.002131849,0.0006914242,0.0001075339,0.0001054806],"genre_scores_gemma":[0.9961283,0.00006943015,0.00003411773,0.0001270272,0.001183796,0.0001240751,0.0003262963,0.00003138456,0.001975603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3772807,"threshold_uncertainty_score":0.3897045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7110187874","doi":"10.1080/23995270.2025.2580913","title":"AIRLEAF <sup>®</sup> –a study of verducatib as a new kind of treatment for bronchiectasis: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Genentech; Grifols; Vertex Pharmaceuticals; AstraZeneca; CSL Behring; Chiesi Farmaceutici; Sanofi; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Pfizer; Bundesministerium für Bildung und Forschung; Insmed; McGill University; Gilead Sciences; Boehringer Ingelheim","keywords":"Bronchiectasis; Exacerbation; Plain language; Placebo; Disease; Pill; Lung disease; Quality of life (healthcare)","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01042191738904794,"gpt":0.3327368808179552,"spread":0.3223149634289072,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005027502,0.0002266056,0.000591455,0.0002490596,0.00006129904,0.00001232803,0.0001706887,0.00005835897,0.0001793723],"category_scores_gemma":[0.0008436646,0.0001724024,0.0002287224,0.0003898298,0.00006514724,0.00007045689,0.00005838661,0.00007794853,0.000004097457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002040598,"about_ca_system_score_gemma":0.001639947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000831436,"about_ca_topic_score_gemma":0.00021323,"domain_scores_codex":[0.9986016,0.00007631656,0.0003448396,0.0003582598,0.0003371089,0.0002819203],"domain_scores_gemma":[0.9984655,0.0004359993,0.00009981708,0.0005605631,0.0001320922,0.0003060085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"qualitative","study_design_scores_codex":[0.03819638,0.02471521,0.1595151,0.00779783,0.00512604,0.0003795397,0.03981703,0.0004820355,0.005056245,0.0007088178,0.3193217,0.398884],"study_design_scores_gemma":[0.06274994,0.04334231,0.2698367,0.005123372,0.006374483,0.00003980862,0.3885342,0.0005568785,0.01389312,0.001000349,0.2074922,0.001056639],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9724507,0.022202,0.00003847017,0.0009938764,0.0001292366,0.002742138,0.0008479143,0.00005474488,0.0005409485],"genre_scores_gemma":[0.994314,0.0001554002,0.0008420434,0.0001377344,0.0005146349,0.00029548,0.0003854527,0.00002951812,0.003325777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3978274,"threshold_uncertainty_score":0.7030365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407406073","doi":"10.1080/23995270.2025.2466383","title":"Letter in reply: orphan drugs approved in Canada: availability and additional therapeutic value","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Wilfrid Laurier University; Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; Fraser Institute","funders":"","keywords":"Orphan drug; Value (mathematics); Medicine; Mathematics; Biology; Bioinformatics; Statistics","authors":[{"name":"Nigel S. B. Rawson","is_ca":true},{"name":"J. F. Adams","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01325555743609485,"gpt":0.2277355903476063,"spread":0.2144800329115115,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001211968,0.0001394899,0.0003048191,0.0001616242,0.00004242096,0.00003676166,0.0001391765,0.00004936523,0.001734576],"category_scores_gemma":[0.00006915155,0.0001573793,0.0000533614,0.0002068753,0.00004557552,0.0001150872,0.00005368797,0.0001625434,0.00002298503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005128309,"about_ca_system_score_gemma":0.0004139983,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1097101,"about_ca_topic_score_gemma":0.1560311,"domain_scores_codex":[0.9988711,0.00002803145,0.0004200389,0.0003972238,0.00002326837,0.0002603467],"domain_scores_gemma":[0.999431,0.0001523036,0.00008036949,0.000224864,0.00000983732,0.0001015964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001291427,0.0002212935,0.593208,0.0001752442,0.00007103615,0.00001932315,0.0001878006,0.00006070543,0.000002367249,0.1493342,0.2503234,0.006267482],"study_design_scores_gemma":[0.0005233453,0.000004174756,0.4583047,0.000016487,0.000003920496,3.642345e-7,0.00005586787,0.001177201,0.000004578924,0.02290712,0.5168571,0.0001451784],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8287176,0.02443658,0.00003752658,0.09103368,0.001800124,0.0009991503,0.02375173,0.0000515418,0.02917206],"genre_scores_gemma":[0.9538714,0.0001997721,0.00002653052,0.0451395,0.0002627679,0.00008373153,0.0002146665,0.00001095564,0.000190735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2665337,"threshold_uncertainty_score":0.999178,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412069038","doi":"10.1080/23995270.2025.2515006","title":"Plain language summary: Patient journey and treatment patterns in progressive pulmonary fibrosis","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Pulmonary fibrosis; Medicine; Field (mathematics); Fibrosis; Intensive care medicine; Pathology; Mathematics","authors":[{"name":"Nazia Chaudhuri","is_ca":false},{"name":"Paolo Spagnolo","is_ca":false},{"name":"Claudia Valenzuela","is_ca":false},{"name":"Valeria C. Amatto","is_ca":true},{"name":"Oliver-Thomas Carter","is_ca":false},{"name":"Lauren Lee","is_ca":false},{"name":"Mark Small","is_ca":false},{"name":"Michael Kreuter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004801572897415728,"gpt":0.2532780850455136,"spread":0.2484765121480979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002312575,0.0002762451,0.0003824554,0.0002115945,0.000102917,0.0000448043,0.00006844961,0.000104779,0.0001522009],"category_scores_gemma":[0.00002934818,0.0002114143,0.0001903458,0.0002022862,0.00005645472,0.000112946,0.0000724612,0.0001236344,0.000004500922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002323536,"about_ca_system_score_gemma":0.0001898709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002258663,"about_ca_topic_score_gemma":0.00004232871,"domain_scores_codex":[0.9987468,0.0000757677,0.0002676803,0.0004044414,0.0001904685,0.0003148767],"domain_scores_gemma":[0.9992883,0.0000476089,0.00006731378,0.0002821935,0.00004944123,0.000265127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01511951,0.003788566,0.7254872,0.001748596,0.0004157696,0.01453597,0.002306742,0.000005776026,0.0006768844,0.0004922896,0.01021746,0.2252052],"study_design_scores_gemma":[0.003288172,0.004262905,0.9405712,0.005799427,0.0009375235,0.0002049426,0.01484729,0.0003338288,0.0004967678,0.0001287863,0.02850711,0.0006220223],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9512426,0.04259772,0.000004835604,0.00203354,0.000371498,0.0008839782,0.001460149,0.00008789502,0.001317741],"genre_scores_gemma":[0.9963521,0.0009613554,0.00004555105,0.0006664647,0.0005105255,0.0001954645,0.0007236538,0.00002300556,0.0005219012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2245831,"threshold_uncertainty_score":0.8621225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415687071","doi":"10.1080/23995270.2025.2570636","title":"Plain Language Summary: kidney function and severe clinical events in people with Fabry disease who receive agalsidase beta","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Global Affairs Canada","funders":"Sanofi","keywords":"Fabry disease; Renal function; BETA (programming language); Kidney disease; Disease","authors":[{"name":"Julie L. Batista","is_ca":true},{"name":"Jerry Walter","is_ca":false},{"name":"Elvira Ponce","is_ca":false},{"name":"Christoph Wanner","is_ca":false},{"name":"Robert J. Desnick","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008033434704794291,"gpt":0.2978692758426545,"spread":0.2898358411378602,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001592491,0.0002651776,0.0004876613,0.0002414058,0.000122048,0.00002997879,0.0001344123,0.0001440818,0.0002527992],"category_scores_gemma":[0.0006912129,0.0002064834,0.0001366876,0.0006340551,0.00009929228,0.0001946321,0.000124584,0.0004007736,0.00001587437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001245685,"about_ca_system_score_gemma":0.0007408815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001582925,"about_ca_topic_score_gemma":0.0004623666,"domain_scores_codex":[0.9979762,0.0002642255,0.0003154219,0.0006072168,0.000454853,0.0003820859],"domain_scores_gemma":[0.9982994,0.0001855809,0.00006680109,0.0004625933,0.0001174476,0.000868241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006714539,0.0006866677,0.9398029,0.0007115215,0.0001549786,0.0004728275,0.000187205,0.000001855359,0.000005727441,0.00008876812,0.03739309,0.01377993],"study_design_scores_gemma":[0.005120307,0.0002542947,0.9836938,0.0009669116,0.0003335471,0.0000070048,0.001737286,0.00007072777,0.000003920835,0.0001360478,0.007454225,0.0002218717],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980596,0.009777464,0.00004816316,0.006494547,0.0002733106,0.001117446,0.0005401277,0.0001032813,0.001049678],"genre_scores_gemma":[0.9912482,0.0004566862,0.00003245949,0.002974788,0.0004546686,0.0001196127,0.001268306,0.000036204,0.00340906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04389096,"threshold_uncertainty_score":0.842015,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408500388","doi":"10.1080/23995270.2025.2466921","title":"Plain language summary of the outcomes from the first Rare Bone Disease Summit: current challenges and priority actions","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Summit; Current (fluid); Medicine; Disease; Intensive care medicine; Geography; Engineering; Internal medicine; Cartography","authors":[{"name":"Inês Alves","is_ca":false},{"name":"Manju Chandran","is_ca":false},{"name":"Emma Albee","is_ca":false},{"name":"Michelle Davis","is_ca":false},{"name":"Edward C. Hsiao","is_ca":false},{"name":"Anna Petryk","is_ca":false},{"name":"Oliver Semler","is_ca":false},{"name":"Marwan Sleiman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009285446319931756,"gpt":0.2503560212204499,"spread":0.2410705749005181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003899324,0.0002056806,0.0001891462,0.00002508571,0.0002755981,0.00003035829,0.0003226888,0.00007164796,0.0000166779],"category_scores_gemma":[0.0001637314,0.0001201228,0.0002544322,0.00007219276,0.0001427562,0.000006464501,0.0003220407,0.0001020261,9.54252e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001311632,"about_ca_system_score_gemma":0.0001814458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003213309,"about_ca_topic_score_gemma":0.0004761632,"domain_scores_codex":[0.9990806,0.00008276767,0.0001785799,0.0003460115,0.0001371766,0.0001748652],"domain_scores_gemma":[0.9989702,0.00007841754,0.00008900746,0.0006800534,0.00005789919,0.000124434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009034088,0.001253833,0.7965169,0.0008087017,0.0009020336,0.00004993265,0.0009248572,0.00002577714,0.001180668,0.001569946,0.1291558,0.0667082],"study_design_scores_gemma":[0.0004145956,0.00001298101,0.8311087,0.0000933714,0.000246085,4.730655e-7,0.001806189,0.000003677507,0.0002337919,0.0001777204,0.1657573,0.0001451188],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6744969,0.3150083,0.000004433376,0.005484717,0.0008327176,0.0003182102,0.00370803,0.00001571718,0.0001308603],"genre_scores_gemma":[0.9857711,0.01244285,0.000008248134,0.0005149151,0.000498141,0.00005007653,0.0005215196,0.00001481812,0.0001783838],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3112741,"threshold_uncertainty_score":0.4898467,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401784358","doi":"10.1080/23995270.2024.2380247","title":"A plain language summary of the NefIgArd trial: Nefecon for the treatment of patients with immunoglobulin A nephropathy","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"AstraZeneca; Omeros Corporation; Alexion Pharmaceuticals; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Antibody; Immunology","authors":[{"name":"Richard Lafayette","is_ca":false},{"name":"Jens Kristensen","is_ca":false},{"name":"Andrew Stone","is_ca":false},{"name":"Jürgen Floege","is_ca":false},{"name":"Vladimı́r Tesař","is_ca":false},{"name":"Hernán Trimarchi","is_ca":false},{"name":"Hong Zhang","is_ca":false},{"name":"Necmi Eren","is_ca":false},{"name":"Alexander Paliege","is_ca":false},{"name":"Heather N. Reich","is_ca":true},{"name":"Brad H. Rovin","is_ca":false},{"name":"Jonathan Barratt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005686959444619518,"gpt":0.2434480502845588,"spread":0.2377610908399392,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003463883,0.0001851343,0.0003291276,0.0000472296,0.00007623922,0.00002168328,0.0001094631,0.00004455169,0.00006546055],"category_scores_gemma":[0.00004959224,0.0000744242,0.0005027758,0.0002132197,0.0001036682,0.00004578558,0.00001968465,0.00004845269,0.000001661839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004563259,"about_ca_system_score_gemma":0.000211115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000055176,"about_ca_topic_score_gemma":0.00002027032,"domain_scores_codex":[0.9990846,0.00004711111,0.0002439497,0.0001946216,0.0002709723,0.0001587742],"domain_scores_gemma":[0.9990649,0.0002325968,0.00009717352,0.000433946,0.00009233408,0.00007904365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3407033,0.01013538,0.1990343,0.008187519,0.004881579,0.0002491054,0.01083053,0.00007109137,0.0003265939,0.001168162,0.04592832,0.3784841],"study_design_scores_gemma":[0.03465078,0.006993634,0.8350562,0.001541262,0.004162775,0.000004545508,0.003663923,0.0000925999,0.0005147351,0.00007952109,0.112983,0.0002569453],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9000318,0.09286509,0.00001019964,0.0007232832,0.0005461666,0.002214554,0.003506691,0.00003974745,0.00006246048],"genre_scores_gemma":[0.9967366,0.001273985,0.00002813913,0.0001534794,0.0007325707,0.0002848872,0.0004026322,0.0000331139,0.0003545189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6360219,"threshold_uncertainty_score":0.3034931,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412676182","doi":"10.1080/23995270.2025.2535273","title":"A plain language summary of the phase 1/2 study of AAV5-hRKp.RPGR (botaretigene sparoparvovec) in people with RPGR-associated X-linked retinitis pigmentosa","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kellogg's (Canada)","funders":"Johnson and Johnson; Moorfields Eye Hospital NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Retinitis pigmentosa; Phase (matter); Medicine; Physics; Ophthalmology","authors":[{"name":"Michel Michaelides","is_ca":false},{"name":"Cagri G. Besirli","is_ca":true},{"name":"James Bainbridge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003337129755909234,"gpt":0.2396379515389264,"spread":0.2363008217830172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001133641,0.0002296162,0.0003542552,0.00007184571,0.00007594471,0.00001527512,0.0003972915,0.0001445438,0.00003336374],"category_scores_gemma":[0.0002119938,0.0001653895,0.0001196539,0.0005033865,0.0001038948,0.000006377465,0.0001601839,0.0001358489,3.466905e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003665727,"about_ca_system_score_gemma":0.0003741734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001553503,"about_ca_topic_score_gemma":0.0009606266,"domain_scores_codex":[0.9985111,0.0002357925,0.0003687996,0.0003778934,0.000267379,0.000239004],"domain_scores_gemma":[0.9989788,0.00004267561,0.000237013,0.0005474348,0.0001348298,0.00005923692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001949424,0.004871637,0.8540499,0.0005806972,0.0005157356,0.00008775006,0.002230509,0.0001224145,0.1296089,0.00004481961,0.003923606,0.002014553],"study_design_scores_gemma":[0.01763579,0.003064955,0.543299,0.001112288,0.000798289,0.000009641984,0.03965623,0.00006002024,0.3899168,0.00007169745,0.003492433,0.0008827914],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922622,0.005978373,0.00002125468,0.0000907913,0.000157568,0.0006056519,0.0003438341,0.00001471375,0.0005255766],"genre_scores_gemma":[0.9984704,0.000264915,0.00002232911,0.0001040328,0.0001170192,0.00007254088,0.0004725801,0.0000220318,0.0004541667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3107509,"threshold_uncertainty_score":0.674439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407710006","doi":"10.1080/23995270.2025.2466380","title":"Orphan drugs approved in Canada: availability and additional therapeutic value","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Orphan drug; Value (mathematics); Medicine; Business; Pharmacology; Mathematics; Statistics; Biology; Bioinformatics","authors":[{"name":"Joel Lexchin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01286622521603255,"gpt":0.2277308317862886,"spread":0.2148646065702561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008377338,0.0001357897,0.0002813221,0.0001082948,0.00006743259,0.00003985945,0.0001428935,0.00005065843,0.002783109],"category_scores_gemma":[0.00006080416,0.0001515578,0.00005908792,0.0001676892,0.00004833902,0.0001013631,0.00005291196,0.0001236477,0.00003443984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004102942,"about_ca_system_score_gemma":0.0005483784,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08226451,"about_ca_topic_score_gemma":0.1004792,"domain_scores_codex":[0.9990302,0.00001990201,0.0003437374,0.0003458195,0.00002227693,0.0002380446],"domain_scores_gemma":[0.9994305,0.0001453569,0.00007824044,0.000198994,0.00001331793,0.0001336134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009897644,0.0001989382,0.288751,0.0001815862,0.0001228054,0.000008272271,0.0001344414,0.00004087598,0.000002209569,0.5757436,0.1221289,0.01258844],"study_design_scores_gemma":[0.0005204068,0.000006030794,0.4372589,0.00001377338,0.000008374323,5.110564e-7,0.0001212948,0.001753134,0.000005073103,0.06195994,0.4981731,0.0001795433],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7413703,0.05973002,0.0001274568,0.04375052,0.003050843,0.001270333,0.06779404,0.0001039311,0.08280256],"genre_scores_gemma":[0.9904802,0.0003010721,0.0000320443,0.008343544,0.0002244777,0.00006452736,0.0002705897,0.00001020111,0.0002733322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5137836,"threshold_uncertainty_score":0.9981285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388536081","doi":"10.2217/frd-2023-0013","title":"Plain language summary of a study looking at whether genetic testing can help doctors diagnose the severity of mucopolysaccharidosis type I (MPS I)","year":2023,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Mucopolysaccharidosis type I; Enzyme replacement therapy; Phenotype; Missense mutation; Genotype; Gene; Genetics; Mucopolysaccharidosis I; Disease; Genotype-phenotype distinction; Enzyme; Biology; Medicine; Biochemistry; Internal medicine","authors":[{"name":"L. Clarke","is_ca":true},{"name":"Roberto Giugliani","is_ca":false},{"name":"Joseph Muenzer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02026119448871626,"gpt":0.300552782468921,"spread":0.2802915879802047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001846041,0.0002004856,0.0003853089,0.0001687256,0.0001537516,0.0000149613,0.0002800029,0.0000701434,0.00034958],"category_scores_gemma":[0.001225799,0.0001380989,0.0001368365,0.001235724,0.0001289565,0.00004068952,0.0002938486,0.000186364,0.00001515605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001011979,"about_ca_system_score_gemma":0.0002213205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001667272,"about_ca_topic_score_gemma":0.0008378692,"domain_scores_codex":[0.9980997,0.0002141223,0.0003082086,0.0003196931,0.0007046316,0.0003535804],"domain_scores_gemma":[0.9983705,0.0005428303,0.0001302984,0.0005654843,0.0002165927,0.0001742986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003120799,0.0005363792,0.977295,0.0004532729,0.0002012751,0.0005038928,0.005633723,0.00002045293,0.002146251,0.000002447253,0.004391642,0.008503552],"study_design_scores_gemma":[0.001024717,0.0004117771,0.9716011,0.0002316566,0.0002775439,0.00001300689,0.02440269,0.00009833131,0.001439756,0.0000184837,0.0003180615,0.0001628781],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927471,0.005173384,7.287314e-7,0.0004015494,0.0001839554,0.000952713,0.0003105926,0.0001042824,0.0001257188],"genre_scores_gemma":[0.9987952,0.000123169,0.00002934831,0.0001008423,0.0003537944,0.00006743817,0.00009398831,0.00004744669,0.0003887417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01876897,"threshold_uncertainty_score":0.5631511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401925418","doi":"10.1080/23995270.2024.2383163","title":"Plain Language Summary: Looking at treatment outcomes in people with Fabry disease who started agalsidase beta before the age of 30 years","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Association of Gastroenterology","funders":"","keywords":"Fabry disease; Medicine; Pediatrics; BETA (programming language); Disease; Internal medicine; Computer science","authors":[{"name":"Robert J. Hopkin","is_ca":false},{"name":"Ana María Martins","is_ca":false},{"name":"Julia Alton","is_ca":true},{"name":"Camilla Tøndel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007470405384718379,"gpt":0.2732195483789067,"spread":0.2657491429941883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007035978,0.0002869585,0.0004905121,0.0002038159,0.00008638862,0.00005658512,0.0001806669,0.00006668585,0.0005507045],"category_scores_gemma":[0.00007785485,0.0001613078,0.0002415349,0.0004931774,0.0001355202,0.0001103437,0.0001042586,0.0001835361,0.00002804866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003831918,"about_ca_system_score_gemma":0.0003270388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005396795,"about_ca_topic_score_gemma":0.004168526,"domain_scores_codex":[0.9981745,0.0001148216,0.0002427524,0.0004211256,0.0006412728,0.0004054554],"domain_scores_gemma":[0.9988943,0.0001477732,0.00004480348,0.0005721363,0.00004580116,0.0002951441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008309534,0.0005693912,0.9678856,0.0007067997,0.0003947668,0.01053529,0.006809517,0.00001415762,0.00006876444,0.00008004186,0.002677376,0.009427415],"study_design_scores_gemma":[0.001820453,0.0003781852,0.9865065,0.0005793301,0.0004074127,0.00001024305,0.004723978,0.0001203974,0.0000515112,0.00002189876,0.005204455,0.0001756449],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771959,0.01780065,0.0000051779,0.002305561,0.00009658988,0.001038786,0.001250577,0.0001095584,0.0001971556],"genre_scores_gemma":[0.9955688,0.0001534639,0.00001193696,0.0002013162,0.0002474305,0.0001505699,0.001211603,0.00006373889,0.002391158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01862097,"threshold_uncertainty_score":0.6577944,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391262940","doi":"10.2217/frd-2023-0024","title":"Plain language summary of efanesoctocog alfa for patients with severe hemophilia A","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clotting factor; Prophylactic treatment; Clinical research; Pediatrics; Surgery; Internal medicine","authors":[{"name":"Annette von Drygalski","is_ca":false},{"name":"Pratima Chowdary","is_ca":false},{"name":"Roshni Kulkarni","is_ca":false},{"name":"Sophie Susen","is_ca":false},{"name":"Barbara A. Konkle","is_ca":false},{"name":"Johannes Oldenburg","is_ca":false},{"name":"Davide Matino","is_ca":true},{"name":"Robert Klamroth","is_ca":false},{"name":"Angela C. Weyand","is_ca":false},{"name":"Víctor Jiménez‐Yuste","is_ca":false},{"name":"Keiji Nogami","is_ca":false},{"name":"Bent Winding","is_ca":false},{"name":"Annemieke Willemze","is_ca":false},{"name":"Karin Knobe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006988405016050799,"gpt":0.2737567799168182,"spread":0.2667683749007674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000348244,0.000172776,0.0002727182,0.0001228764,0.00005433368,0.00002031277,0.00007615951,0.00007879046,0.0002387077],"category_scores_gemma":[0.00005047192,0.0001037403,0.0001718926,0.0002278145,0.00005804413,0.00007877596,0.00002640312,0.00009846222,0.00001550083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005303201,"about_ca_system_score_gemma":0.0002195841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008272888,"about_ca_topic_score_gemma":0.000005790128,"domain_scores_codex":[0.9989464,0.00002211406,0.0001450593,0.0002764638,0.0003621416,0.000247858],"domain_scores_gemma":[0.9992716,0.000135546,0.00002418483,0.000245669,0.0001193694,0.0002036216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0079676,0.00286616,0.6469406,0.01165869,0.001543966,0.001804639,0.002171077,0.000002721166,0.0003187614,0.0005904008,0.237625,0.08651038],"study_design_scores_gemma":[0.02121427,0.007353511,0.695168,0.006243879,0.002982046,0.0001072552,0.004756557,0.0002758507,0.002265972,0.0005261078,0.2578425,0.001264135],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806215,0.01155026,0.000007489537,0.001632987,0.0002551584,0.002117167,0.002490256,0.0001528897,0.00117226],"genre_scores_gemma":[0.9909143,0.00007721048,0.0002432947,0.000115912,0.0009091101,0.0001932782,0.002644922,0.00004956639,0.004852353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08524624,"threshold_uncertainty_score":0.4230408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}